Researchers at the University of Cambridge and the University of Oxford have discovered a new molecule that plays a key role in the immune response that is triggered by influenza infections.
The molecule, a so-called mini viral RNA, is capable of inducing inflammation and cell death, and was produced at high levels by the 1918 pandemic influenza virus. The findings appear in Nature Microbiology.
Influenza is one of the main infectious diseases in humans. Seasonal influenza viruses account for about 650,000 deaths per year, whereas pandemic strains such as the 1918 H1N1 virus have been linked to 50-100 million deaths worldwide. Highly pathogenic avian influenza viruses such as the H5N1 and H7N9 strains have a mortality rate of about 50% in humans.
The reasons for difference in disease severity and lethality caused by seasonal influenza viruses on the one hand, and pandemic and highly pathogenic avian influenza viruses on the other hand, is still poorly understood. Previous research has indicated that in infections with the 1918 pandemic virus or infections with an H5N1 avian virus, a powerful immune response is established that leads to death. This led Professor Ervin Fodor and his colleagues Dr Josh Long and Dr David Bauer of the University of Oxford, and Dr Aartjan te Velthuis of the University of Cambridge, to ask what viral molecule can trigger this powerful immune response.
The British groups first looked to how viruses are detected by the cell. Normally, an infected cell spots the presence of a virus by sensing the genetic material of the virus, RNA in the case of flu. Work by Prof Richard Randall, a collaborator on the manuscript from the University of St Andrews, has shown that influenza viruses are good at hiding their RNA. This observation prompted Fodor and his colleagues to look for flu RNA that the virus was not able to hide from the cellular pathogen sensing system. What they found was truncated pieces of the viral genome that the virus had produced in error. The researchers called these pieces mini viral RNAs.
Fodor and his colleagues next investigated whether different influenza viruses produce mini viral RNAs at different frequencies and whether there was a link with the strong innate immune response that, for instance, the 1918 pandemic virus induces. A combination of in vitro and in vivo experiments performed at Oxford, Cambridge, the University of Hong Kong, the Erasmus Medical Centre, and the Rocky Mountain Laboratories, revealed indeed a strong correlation between the ability of an influenza virus to generate mini viral RNAs and the amount of inflammation and cell death the virus infection caused.
'We think it is a significant breakthrough and that it is particularly exciting that we are finding this factor a hundred years after the 1918 pandemic,' comments Dr te Velthuis, one of the lead authors of the study.
The research groups are now continuing their efforts to investigate whether there is a causal link between influenza virus mortality and the production of mini viral RNAs. Together with their latest work, these efforts may help us understand better how influenza viruses cause disease, how we can identify dangerous influenza viruses, and how to develop new antivirals against influenza virus infections.
The full paper, 'Mini viral RNAs act as innate immune agonists during influenza virus infection,' can be read in the journal Nature Microbiology.
The work was funded by the Wellcome Trust, Royal Society, Medical Research Council, NIH, and the Netherlands Organization for Scientific Research.